1. Home
  2. RNAC vs FOCL Comparison

RNAC vs FOCL Comparison

Compare RNAC & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

N/A

Current Price

$7.98

Market Cap

238.9M

Sector

Health Care

ML Signal

N/A

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$6.13

Market Cap

203.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNAC
FOCL
Founded
2007
N/A
Country
United States
France
Employees
N/A
289
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.9M
203.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
RNAC
FOCL
Price
$7.98
$6.13
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
155.3K
44.3K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,797,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.60
$4.76
52 Week High
$13.96
$6.18

Technical Indicators

Market Signals
Indicator
RNAC
FOCL
Relative Strength Index (RSI) 41.23 88.29
Support Level $5.89 $5.30
Resistance Level $8.39 N/A
Average True Range (ATR) 0.56 0.19
MACD -0.21 0.06
Stochastic Oscillator 13.51 93.75

Price Performance

Historical Comparison
RNAC
FOCL

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Share on Social Networks: